SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Requested Dosing Extension

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
falconer66a Member Profile
 
Followed By 51
Posts 419
Boards Moderated 0
Alias Born 01/29/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 5:15:55 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/11/2017 5:22:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/11/2017 4:42:04 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/7/2017 4:41:07 PM
Anavex Reports Fiscal Third Quarter 2017 Financial Results "GlobeNewswire Inc." - 8/7/2017 7:00:00 AM
Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board "GlobeNewswire Inc." - 7/20/2017 7:00:00 AM
Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments "NetworkNewsWire" - 6/15/2017 7:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/13/2017 6:03:09 AM
Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference "GlobeNewswire Inc." - 6/5/2017 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/26/2017 4:32:21 PM
Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... "GlobeNewswire Inc." - 5/22/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:54:40 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:54:40 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2017 4:29:05 PM
Anavex Reports Fiscal Second Quarter 2017 Financial Results "GlobeNewswire Inc." - 5/10/2017 7:00:00 AM
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs "GlobeNewswire Inc." - 5/1/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/21/2017 6:09:35 AM
Positive News in the Fight against Cancer Fuels Quest for More Good Tidings "NetworkNewsWire" - 4/18/2017 8:45:00 AM
Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor "GlobeNewswire Inc." - 4/3/2017 7:00:00 AM
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit "GlobeNewswire Inc." - 3/30/2017 8:00:00 AM
Anavex Life Sciences to Present at the 13th International Conference on Alzheimer's and Parkinson's Diseases AD/PD™ 2017 "GlobeNewswire Inc." - 3/29/2017 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/17/2017 6:06:45 AM
Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference "GlobeNewswire Inc." - 3/15/2017 7:00:00 AM
Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference "GlobeNewswire Inc." - 3/13/2017 7:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/10/2017 7:17:05 AM
falconer66a   Saturday, 06/24/17 10:45:47 PM
Re: whippinsaw post# 109574
Post # of 115864 
Requested Dosing Extension

Here's another extremely revealing statement from the article:

Quote:
The extension phase was originally planned to last 6 months, but patients and caregivers wanted to continue on the medication, so the company extended it to 12 months. It is ongoing.



Put your fingers on your keyboard and list out all of the possible reasons patients and caregivers wanted to stay on Anavex 2-73. What did I miss?

1. They liked the taste of the pills, and liked the smiles of their patients taking it.

2. They were hoping to get paid to continue participation in the trial.

3. The patients were finally getting good nights of sleep.

4. The patients actually were feeling and thinking better.

5. It was all a coincidence; no actual symptomatic improvement during the trial, so they were hoping things would eventually get better over a longer dosing period.

6. They all had a wry sense of humor, knowing that the request would confound both researchers and perplex regulators and drug company shareholders.

7. None of this actually happened. It was a made-up story by Anavex reseachers.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist